Geode Capital Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $780M | Buy |
2,398,770
+75,936
| +3% | +$24.7M | 0.05% | 304 |
|
2025
Q1 | $626M | Buy |
2,322,834
+116,034
| +5% | +$31.3M | 0.05% | 335 |
|
2024
Q4 | $518M | Buy |
2,206,800
+59,597
| +3% | +$14M | 0.04% | 382 |
|
2024
Q3 | $589M | Buy |
2,147,203
+66,928
| +3% | +$18.4M | 0.05% | 341 |
|
2024
Q2 | $505M | Buy |
2,080,275
+78,557
| +4% | +$19.1M | 0.04% | 350 |
|
2024
Q1 | $299M | Buy |
2,001,718
+74,982
| +4% | +$11.2M | 0.03% | 487 |
|
2023
Q4 | $368M | Buy |
1,926,736
+87,231
| +5% | +$16.7M | 0.04% | 409 |
|
2023
Q3 | $325M | Buy |
1,839,505
+37,483
| +2% | +$6.63M | 0.04% | 412 |
|
2023
Q2 | $342M | Buy |
1,802,022
+63,907
| +4% | +$12.1M | 0.04% | 400 |
|
2023
Q1 | $348M | Buy |
1,738,115
+48,186
| +3% | +$9.64M | 0.05% | 383 |
|
2022
Q4 | $401M | Buy |
1,689,929
+90,455
| +6% | +$21.5M | 0.06% | 335 |
|
2022
Q3 | $320M | Buy |
1,599,474
+26,771
| +2% | +$5.35M | 0.05% | 364 |
|
2022
Q2 | $229M | Buy |
1,572,703
+2,420
| +0.2% | +$353K | 0.03% | 461 |
|
2022
Q1 | $256M | Buy |
1,570,283
+64,992
| +4% | +$10.6M | 0.03% | 482 |
|
2021
Q4 | $255M | Buy |
1,505,291
+51,272
| +4% | +$8.68M | 0.03% | 488 |
|
2021
Q3 | $274M | Buy |
1,454,019
+8,001
| +0.6% | +$1.51M | 0.04% | 448 |
|
2021
Q2 | $245M | Buy |
1,446,018
+59,719
| +4% | +$10.1M | 0.03% | 470 |
|
2021
Q1 | $195M | Buy |
1,386,299
+77,166
| +6% | +$10.9M | 0.03% | 506 |
|
2020
Q4 | $170M | Buy |
1,309,133
+49,330
| +4% | +$6.4M | 0.03% | 511 |
|
2020
Q3 | $183M | Sell |
1,259,803
-24,493
| -2% | -$3.56M | 0.04% | 430 |
|
2020
Q2 | $190M | Sell |
1,284,296
-69,632
| -5% | -$10.3M | 0.04% | 390 |
|
2020
Q1 | $147M | Buy |
1,353,928
+114,441
| +9% | +$12.4M | 0.04% | 398 |
|
2019
Q4 | $143M | Buy |
1,239,487
+50,788
| +4% | +$5.84M | 0.03% | 496 |
|
2019
Q3 | $95.5M | Buy |
1,188,699
+128,504
| +12% | +$10.3M | 0.02% | 587 |
|
2019
Q2 | $76.9M | Buy |
1,060,195
+53,973
| +5% | +$3.91M | 0.02% | 673 |
|
2019
Q1 | $94M | Buy |
1,006,222
+90,689
| +10% | +$8.47M | 0.02% | 561 |
|
2018
Q4 | $66.7M | Buy |
915,533
+34,770
| +4% | +$2.53M | 0.02% | 619 |
|
2018
Q3 | $77M | Buy |
880,763
+74,018
| +9% | +$6.47M | 0.02% | 602 |
|
2018
Q2 | $79.4M | Buy |
806,745
+41,401
| +5% | +$4.07M | 0.02% | 576 |
|
2018
Q1 | $91.1M | Buy |
765,344
+17,698
| +2% | +$2.11M | 0.03% | 523 |
|
2017
Q4 | $94.9M | Buy |
747,646
+88,119
| +13% | +$11.2M | 0.03% | 503 |
|
2017
Q3 | $77.5M | Sell |
659,527
-2,878
| -0.4% | -$338K | 0.03% | 533 |
|
2017
Q2 | $52.8M | Buy |
662,405
+85,608
| +15% | +$6.83M | 0.02% | 632 |
|
2017
Q1 | $29.6M | Buy |
576,797
+42,781
| +8% | +$2.19M | 0.01% | 896 |
|
2016
Q4 | $20M | Buy |
534,016
+14,111
| +3% | +$528K | 0.01% | 1081 |
|
2016
Q3 | $35.2M | Buy |
519,905
+20,289
| +4% | +$1.37M | 0.02% | 699 |
|
2016
Q2 | $27.7M | Buy |
499,616
+19,435
| +4% | +$1.08M | 0.02% | 761 |
|
2016
Q1 | $30.1K | Buy |
480,181
+31,627
| +7% | +$1.98K | 0.02% | 711 |
|
2015
Q4 | $42.2M | Buy |
448,554
+10,371
| +2% | +$976K | 0.02% | 571 |
|
2015
Q3 | $35.2M | Buy |
438,183
+3,827
| +0.9% | +$307K | 0.02% | 625 |
|
2015
Q2 | $52M | Buy |
434,356
+23,380
| +6% | +$2.8M | 0.03% | 517 |
|
2015
Q1 | $42.9M | Buy |
410,976
+63,014
| +18% | +$6.58M | 0.02% | 566 |
|
2014
Q4 | $33.8M | Buy |
347,962
+18,137
| +5% | +$1.76M | 0.02% | 627 |
|
2014
Q3 | $25.8M | Buy |
329,825
+5,617
| +2% | +$439K | 0.02% | 709 |
|
2014
Q2 | $20.5M | Buy |
324,208
+10,614
| +3% | +$670K | 0.01% | 833 |
|
2014
Q1 | $21.1M | Buy |
313,594
+28,989
| +10% | +$1.95M | 0.01% | 789 |
|
2013
Q4 | $18.3M | Buy |
284,605
+32,238
| +13% | +$2.07M | 0.01% | 831 |
|
2013
Q3 | $16.2M | Buy |
252,367
+32,709
| +15% | +$2.09M | 0.01% | 791 |
|
2013
Q2 | $6.81M | Buy |
+219,658
| New | +$6.81M | 0.01% | 1210 |
|